β-Blockers (BBs) are an essential class of cardiovascular medications for reducing morbidity
and mortality in patients with heart failure (HF). However, a large body of data indicates that …

Nitric Oxide (NO) is a small molecule that continues to attract much attention from the
scientific community. Since its discovery, it has been evident that NO has a crucial role in the …

Introduction. Nebivolol, a beta blocker with 3–10 times more β1 cardioselectivity than
metoprolol, has caused hypotension and bradycardia in overdose. We report a nebivolol …

This MiniReview reports the current knowledge about the treatment of arterial hypertension
with the third‐generation beta‐adrenoceptor antagonist (BAA) nebivolol. Furthermore, it …

Uveal melanoma (UM) is the most common primary cancer of the eye in adults. A new
systemic therapy is needed to reduce the high metastasis and mortality rate. As β-blockers …

Nebivolol is a beta-1 receptor blocker used to treat hypertension, heart failure, erectile
dysfunction, vascular disease, and diabetes mellitus. This review investigated the data …

Nebivolol is a β1-adrenergic blocker that also elicits renal vasodilation and increases the
glomerular filtration rate (GFR). However, its direct actions on the renal microvasculature …

Hypertension is an asymptomatic condition of persistently elevated blood pressure (BP) that
affects approximately 50 million Americans and one billion people worldwide. 1, 2 It has …

What is known and objective Nebivolol is a highly selective beta‐blocker with additional
vasodilator properties, widely used in the clinical practice for the treatment of hypertension …

Results Nebivolol/4-OH-nebivolol AUC metabolic ratios were not characterized by a
standard normal distribution. The unique distribution emphasized the existence of two …